b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">\n        <PMID Version="1">30297636</PMID>\n        <DateRevised>\n            <Year>2019</Year>\n            <Month>11</Month>\n            <Day>20</Day>\n        </DateRevised>\n        <Article PubModel="Electronic">\n            <Journal>\n                <ISSN IssnType="Print">2076-3921</ISSN>\n                <JournalIssue CitedMedium="Print">\n                    <Volume>7</Volume>\n                    <Issue>10</Issue>\n                    <PubDate>\n                        <Year>2018</Year>\n                        <Month>Oct</Month>\n                        <Day>08</Day>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Antioxidants (Basel, Switzerland)</Title>\n                <ISOAbbreviation>Antioxidants (Basel)</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Reduction of Real-Time Imaging of M1 Macrophage Chemotaxis toward Damaged Muscle Cells is PI3K-Dependent.</ArticleTitle>\n            <ELocationID EIdType="pii" ValidYN="Y">E138</ELocationID>\n            <ELocationID EIdType="doi" ValidYN="Y">10.3390/antiox7100138</ELocationID>\n            <Abstract>\n                <AbstractText>Macrophages migrate and invade into damaged muscle rapidly and are important for muscle repair and subsequent regeneration. The exact cellular and biological events that cause macrophage migration toward injured muscle are not completely understood. In this study, the effect of macrophage differentiation on the chemotactic capability to invade local damaged muscle was investigated using an in vitro model of muscle injury. We used C2C12 cell myoblasts and J774 cell macrophages, and the &quot;killed-C2C12&quot; cells were combined with live C2C12 cells as a partially damaged muscle model. The cultured J774 cells, with or without lipopolysaccharide (LPS), were treated with Ly294002 (Ly), which is an inhibitor of phosphoinositide 3-kinase (PI3K). In order to evaluate the polarization effect of LPS stimulation on J774 cells, expression of cell surface Toll-like receptor 4 (TLR4), CD11c and CCR2, and expression of F-actin intensity, were analyzed by flow cytometry. The real-time horizontal chemotaxis assay of J774 cells was tested using the TAXIScan device. The expressions of TLR4, CD11c, and F-actin intensity in LPS-treated cells were significantly higher than those in Ctrl cells. In LPS-treated cells, the chemotactic activity toward damaged muscle cells completely disappeared. Moreover, the reduced chemotaxis depended far more on directionality than velocity. However, Ly treatment reversed the reduced chemotactic activity of the LPS-treated cells. In addition, cell-adhesion and F-actin intensity, but not CCR2 expression, in LPS-treated cells, was significantly reduced by Ly treatment. Taken together, our results suggest that the PI3K/Akt activation state drives migration behavior towards damaged muscle cells.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Yano</LastName>\n                    <ForeName>Hiromi</ForeName>\n                    <Initials>H</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Health &amp; Sports Science, Kawasaki University of Medical Welfare, 288 Matsushima Kurashiki, Okayama 701-0193, Japan. yanohiro@mw.kawasaki-m.ac.jp.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Uchida</LastName>\n                    <ForeName>Masataka</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Faculty of Sport and Health Science, Ritsumeikan University, Shiga 525-8577, Japan. m-uchida@fc.ritsumei.ac.jp.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Saito</LastName>\n                    <ForeName>Tatsuya</ForeName>\n                    <Initials>T</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Health &amp; Sports Science, Kawasaki University of Medical Welfare, 288 Matsushima Kurashiki, Okayama 701-0193, Japan. t.saito@mw.kawasaki-m.ac.jp.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Aoki</LastName>\n                    <ForeName>Takafumi</ForeName>\n                    <Initials>T</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Graduate School of Health Science and Technology, Kawasaki University of Medical Welfare, Okayama 701-0193, Japan. aoki.takafumi.54331@mw.kawasaki-m.ac.jp.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Kremenik</LastName>\n                    <ForeName>Michael J</ForeName>\n                    <Initials>MJ</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Health &amp; Sports Science, Kawasaki University of Medical Welfare, 288 Matsushima Kurashiki, Okayama 701-0193, Japan. kremelin@mw.kawasaki-m.ac.jp.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Oyanagi</LastName>\n                    <ForeName>Eri</ForeName>\n                    <Initials>E</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Health &amp; Sports Science, Kawasaki University of Medical Welfare, 288 Matsushima Kurashiki, Okayama 701-0193, Japan. eri-oyanagi@mw.kawasaki-m.ac.jp.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <GrantList CompleteYN="Y">\n                <Grant>\n                    <GrantID>C-24500878 and 15H03102</GrantID>\n                    <Agency>Japan Society for the Promotion of Science</Agency>\n                    <Country/>\n                </Grant>\n                <Grant>\n                    <GrantID>15-D</GrantID>\n                    <Agency>Interdepartmental Research Fund of Kawasaki University of Medical Welfare</Agency>\n                    <Country/>\n                </Grant>\n            </GrantList>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2018</Year>\n                <Month>10</Month>\n                <Day>08</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Switzerland</Country>\n            <MedlineTA>Antioxidants (Basel)</MedlineTA>\n            <NlmUniqueID>101668981</NlmUniqueID>\n            <ISSNLinking>2076-3921</ISSNLinking>\n        </MedlineJournalInfo>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">C2C12</Keyword>\n            <Keyword MajorTopicYN="N">J774</Keyword>\n            <Keyword MajorTopicYN="N">Ly294002</Keyword>\n            <Keyword MajorTopicYN="N">TAXIScan</Keyword>\n            <Keyword MajorTopicYN="N">lipopolysaccharide</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2018</Year>\n                <Month>08</Month>\n                <Day>07</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2018</Year>\n                <Month>09</Month>\n                <Day>25</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2018</Year>\n                <Month>10</Month>\n                <Day>04</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>10</Month>\n                <Day>10</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>10</Month>\n                <Day>10</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2018</Year>\n                <Month>10</Month>\n                <Day>10</Day>\n                <Hour>6</Hour>\n                <Minute>1</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>epublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">30297636</ArticleId>\n            <ArticleId IdType="pii">antiox7100138</ArticleId>\n            <ArticleId IdType="doi">10.3390/antiox7100138</ArticleId>\n            <ArticleId IdType="pmc">PMC6210562</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Cell Biol Int. 2018 Apr 16;:null</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29663649</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>F1000Prime Rep. 2014 Mar 03;6:13</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24669294</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Basic Clin Pharmacol Toxicol. 2015 Jan;116(1):53-61</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24975165</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Leukoc Biol. 2015 Jan;97(1):61-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25359998</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Biol Chem. 2014 May 30;289(22):15788-97</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24713702</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>FEBS Lett. 2003 Aug 28;550(1-3):94-100</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12935893</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Physiol Regul Integr Comp Physiol. 2010 Jun;298(6):R1485-95</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20393160</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Curr Opin Cell Biol. 2003 Oct;15(5):590-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">14519394</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Exerc Immunol Rev. 2010;16:105-18</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20839495</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Commun. 2014 Jul 15;5:4407</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25022365</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Appl Physiol (1985). 2017 Mar 1;122(3):559-570</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28035017</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Immunol Methods. 2013 Jul 31;393(1-2):61-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23603617</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Pharm. 2018 Jul 2;15(7):2721-2731</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29791797</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Biol Chem. 2008 Dec 19;283(51):35715-23</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18977759</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>FEBS Lett. 2017 Oct;591(19):3007-3021</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28555751</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>BMC Cancer. 2017 Mar 31;17(1):234</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28359316</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Physiol Regul Integr Comp Physiol. 2010 May;298(5):R1173-87</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20219869</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Leukoc Biol. 1997 Nov;62(5):653-60</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">9365120</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Annu Rev Biophys. 2010;39:449-70</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20192778</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biomed Res Int. 2014;2014:560629</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24860823</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Pathol. 2014 Apr;184(4):1167-1184</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24525152</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Neuroinflammation. 2014 Feb 01;11:23</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24485070</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>FASEB J. 2011 Jan;25(1):358-69</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20889618</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Immunol Methods. 2007 Mar 30;320(1-2):155-63</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17289072</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Leukoc Biol. 1999 Apr;65(4):492-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10204578</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Physiol. 2003 Feb 15;547(Pt 1):125-32</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12562965</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Exp Med. 2007 May 14;204(5):1057-69</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17485518</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Cell Biol. 2011 Oct 17;195(2):307-22</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21987635</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Cell Biochem. 2012 Jan;113(1):80-92</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21898535</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Annu Rev Cell Dev Biol. 2005;21:247-69</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16212495</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Dev Biol. 2004 Jan 1;265(1):23-32</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">14697350</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br J Pharmacol. 2007 Jul;151(5):638-46</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17471173</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'